This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Ucl Business Plc. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Justin Neil Darrel Warne: Innovator in Mitochondrial Targeting
Introduction
Justin Neil Darrel Warne is a notable inventor based in Wallington, GB. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on mitochondrial targeting compounds.
Latest Patents
Warne holds a patent for "Quinolinium conjugates of cyclosporin." This invention relates to conjugates of cyclosporin with quinolium mitochondrial targeting groups, which have potential therapeutic uses. His work in this area showcases the intersection of chemistry and medicine, aiming to enhance the efficacy of treatments.
Career Highlights
Warne is associated with UCL Business Plc, where he continues to develop and refine his innovative ideas. His career reflects a commitment to advancing scientific knowledge and practical applications in healthcare.
Collaborations
Throughout his career, Warne has collaborated with esteemed colleagues, including David Lawrence Selwood and David Baker. These partnerships have likely contributed to the depth and impact of his research.
Conclusion
Justin Neil Darrel Warne exemplifies the spirit of innovation in the pharmaceutical industry. His work on quinolinium conjugates of cyclosporin highlights the importance of targeted therapies in modern medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile